Edition:
United States

People: Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

26.88USD
29 Mar 2017
Change (% chg)

$-0.16 (-0.57%)
Prev Close
$27.03
Open
$27.07
Day's High
$27.50
Day's Low
$26.55
Volume
350,685
Avg. Vol
414,480
52-wk High
$41.69
52-wk Low
$23.07

Kumar, Ravindra 

Dr. Ravindra Kumar, Ph.D., is Senior Vice President, Chief Scientific Officer of Acceleron Pharma, Inc. He joined Acceleron in March 2004. Dr. Kumar established and currently leads company discovery research. Previously, Dr. Kumar worked for 12 years at Genetics Institute and Wyeth Pharmaceuticals. At Genetics Institute, Dr. Kumar was a key member of the Small Molecule Drug Discovery group and was responsible for cell biology. Following the integration of discovery functions from Genetics Institute and Wyeth Pharmaceuticals, Dr. Kumar served as Senior Scientist in the Biological Chemistry group. Dr. Kumar is the author of several key scientific manuscripts in the area of protein glycosylation and is named as an inventor of several patents. Dr. Kumar received his BS in chemistry from Rohilkhand University, his MS in chemistry from Meerut University, his Ph.D. from University of New Brunswick and he completed his post-doctoral fellowship at Albert Einstein College of Medicine, in Bronx, NY.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Francois Nader

284,962

Habib Dable

--

Kevin McLaughlin

2,756,410

Steven Ertel

4,278,920

Matthew Sherman

3,417,170

Ravindra Kumar

--
As Of  30 Dec 2015